Invivoscribe Announces a Regional “Center of Excellence” Reference Laboratory in Beirut to Offer Specialized Gene Panels
⟵ PRESS RELEASES PRESS RELEASE SAN DIEGO, [...]
Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations
⟵ PRESS RELEASES PRESS RELEASE SAN DIEGO, [...]